2m 2m 2m 2m 2m 2m 2m
The Joint (JYNT)
NASDAQ
$8.32+$0.11 (+1.34%)
Price as of Aug 04, 2026 12:29 PM EDT- $117.0MMarket Cap
- -26.57%1-Year Change
- Medical Care FacilitiesIndustry
The Joint (JYNT)
$8.32+$0.11 (+1.34%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 33.2M +3.29% | 32.1M -72.69% | 117.7M +16.24% | 101.3M +25.22% | |
Cost of Revenue | 11.2M -2.53% | 11.5M +9.20% | 10.5M +15.00% | 9.2M +7.72% | |
Gross Profit | 22.0M +6.55% | 20.6M -80.75% | 107.1M +16.36% | 92.1M +27.28% | |
Sales and Marketing Expense | 13.3M +21.19% | 11.0M -33.66% | 16.5M +18.47% | 14.0M +22.22% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 1.7M -63.71% | 4.7M -44.98% | 8.6M +29.12% | 6.6M +9.16% | |
Total Operating Expenses | 9.5M -5.60% | 10.1M -4.58% | 10.5M -37.87% | 17.0M +99.38% | |
Operating Profit | -913,376 -51.65% | -1.9M -8.88% | -2.1M -350.30% | 828,254 -84.53% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 683,872 +143.99% | 280,287 -92.45% | 3.7M +2,888.74% | -133,101 +90.48% | |
Income before Taxes | -229,504 -85.73% | -1.6M -198.17% | 1.6M +135.74% | 695,153 -86.84% | |
Income Taxes | 38,653 +589.49% | 5,606 -99.95% | 11.4M +16,541.76% | 68,448 +105.29% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 2.9M +150.15% | -5.8M -40.56% | -9.8M -1,656.11% | 626,705 -90.47% | |
Net Income from Continuing Operations Applicable to Common | -229,504 -85.73% | -1.6M -198.17% | 1.6M +135.74% | 695,153 -86.84% | |
Basic EPS and Net Income | 0.19 +148.72% | -0.39 -40.91% | -0.66 -1,750.00% | 0.04 -91.30% | |
Diluted EPS and Net Income | 0.19 +150.00% | -0.38 -41.54% | -0.65 -1,725.00% | 0.04 -90.91% | |
Basic Weighted Average Shares | 15.1M +1.44% | 14.9M +1.57% | 14.7M +1.38% | 14.5M +1.18% | |
Diluted Weighted Average Shares | 15.2M +0.26% | 15.1M +1.42% | 14.9M +0.45% | 14.9M -0.45% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 23.6M -5.79% | 25.1M +38.00% | 18.2M +86.29% | 9.7M -50.09% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 23.6M -5.79% | 25.1M +38.00% | 18.2M +86.29% | 9.7M -50.09% | |
Total Current Assets | 52.1M -30.16% | 74.6M +68.21% | 44.3M +151.70% | 17.6M -34.49% | |
Accumulated Depreciation | 7.5M +25.56% | 6.0M -50.17% | 12.0M -5.28% | 12.7M +38.00% | |
Property and Plant and Equipment and Net | 3.2M -1.48% | 3.2M -70.96% | 11.0M -36.80% | 17.5M +21.45% | |
Total Long-Term Assets | 3.2M -1.48% | 3.2M +35.83% | 2.4M -82.71% | 13.7M +20.12% | |
Total Assets | 61.0M -26.68% | 83.2M -4.59% | 87.2M -6.78% | 93.5M +9.40% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 0 N/A | 0 -100.00% | 2.0M 0.00% | 2.0M 0.00% | |
Total Current Liabilities | 32.8M -33.08% | 49.0M +46.07% | 33.6M +44.61% | 23.2M +8.30% | |
Total Long-Term Debt | 2.0M 0.00% | 2.0M 0.00% | 2.0M 0.00% | 2.0M 0.00% | |
Total Long-Term Liabilities | 12.7M N/A | 0 -100.00% | 1.2M -4.09% | 1.3M +4,629.63% | |
Total Liabilities | 45.9M -26.55% | 62.5M +0.16% | 62.4M +2.42% | 60.9M +8.98% | |
Retained Earnings | -24.8M -10.49% | -27.7M +26.46% | -21.9M +80.24% | -12.2M -10.10% | |
Total Stockholders Equity | 15.1M -27.11% | 20.7M -16.54% | 24.7M -24.00% | 32.6M +10.22% | |
Total Shares Outstanding | 14.1M -6.71% | 15.2M +2.77% | 14.8M +1.54% | 14.5M +0.75% | |
Cash Flow | |||||
Cash from Operating Activities | 1.8M -80.47% | 9.4M -35.85% | 14.7M +78.79% | 8.2M -46.11% | |
Capital Expenditures | 1.5M +26.83% | 1.2M -76.28% | 5.0M -15.26% | 5.9M -15.60% | |
Cash from Investing Activities | 6.3M +1,093.51% | -631,547 -89.79% | -6.2M -65.43% | -17.9M +26.56% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -9.8M +390.05% | -2.0M -1,249.41% | 174,121 -47.01% | 328,610 +116.46% | |
Financials Ratio | |||||
Gross Margin | 66.19% +3.15% | 64.17% -29.51% | 91.04% +0.11% | 90.94% +1.64% | |
Operating Margin | -2.75% -53.19% | -5.88% +233.63% | -1.76% -315.33% | 0.82% -87.64% | |
Return on Assets | 4.03% +159.26% | -6.81% -36.95% | -10.80% -1,641.59% | 0.70% -91.95% | |
Return on Equity | 16.28% +163.77% | -25.54% -24.96% | -34.03% -1,786.40% | 2.02% -92.28% | |
Revenue Growth | 3.29% +104.53% | -72.69% -547.57% | 16.24% -35.60% | 25.22% -33.26% | |
Current Ratio | 1.59 +4.38% | 1.52 +15.16% | 1.32 +74.05% | 0.76 -39.51% | |
Cash Ratio | 0.72 +40.80% | 0.51 -5.53% | 0.54 +28.83% | 0.42 -53.92% | |
Debt-to-Equity Ratio | 0.13 +37.19% | 0.10 -40.10% | 0.16 +31.60% | 0.12 -9.31% | |
Debt-to-Assets Ratio | 0.03 +36.10% | 0.02 -47.49% | 0.05 +7.24% | 0.04 -8.55% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow